Clinical Trials, Drug Manufacturers, Technology

Unscrambler X Process Pulse II

By CAMO Software

In 2004, the FDA issued the process analytical technology (PAT) framework guidance in order to support innovation and efficiency in pharmaceutical development, manufacturing and quality assurance.

This framework has been defined by the agency as 'a system for designing, analysing, and controlling manufacturing through timely measurements (during processing) of critical quality and performance attributes of raw and in-process materials and processes, with the goal of ensuring final product quality.'

The PAT framework propounds process scientific understanding in order to facilitate sound innovation and risk-based decision making.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.